Q Fever News and Research

RSS

GAVI welcomes lower pentavalent vaccine price

In the lead up to its first pledging conference on June 13, the GAVI Alliance announced today it has achieved commitments from two emerging market vaccine manufacturers to lower prices for the life-saving pentavalent vaccine, which protects against five deadly diseases. Developed country manufacturers have also offered price reductions on rotavirus and human papillomavirus, or HPV, vaccines.

5 Jun 2011

Ross River Fever vaccine trials begin

Australian researchers are working on a new vaccine that could protect against mosquito-borne Ross River Fever. They are conducting the world-first trial of the vaccine with positive results reported so far.

5 Jun 2011

MRSA found in cow’s milk

Scientists have discovered a new strain of the drug-resistant germ known as MRSA in cow’s milk and some evidence that the animals could be a source of the infection in humans.

5 Jun 2011

American College of Gastroenterology offers resources on foodborne illness, tips for food safety

For consumers in the United States concerned by the outbreak of E. coli in Europe, the American College of Gastroenterology offers background on foodborne illness, tips for food safety, and expert insight from its resources on digestive health on what to do in the case of foodborne illness.

4 Jun 2011

New Kaiser Family Foundation tool shows which global health interventions are working

Today, the Kaiser Family Foundation unveiled an innovative, online tool that allows users to learn quickly and easily about which global health interventions work. The Global Health Intervention Review (GHIR) compiles the latest information on the efficacy of key global health interventions, including the strength of the evidence, and presents the information in a variety of accessible formats. Users can view a comprehensive overview and a key findings table.

2 Jun 2011

Flu cases rise by 50% in Queensland: Residents alerted

According latest reports, flu cases in Queensland have increased by more than half since last year, causing concern among doctors about an early on-set of flu season. The Australian Medical Association Queensland has revealed close to 1600 cases of flu have been reported across the state this year, with as many as 460 cases reported over the last five weeks alone. They add that that as many as 30 per cent of the flu cases reported were the H1N1 virus, more commonly known as swine flu.

2 Jun 2011

New study identifies odor molecules that disrupt CO2-sensing machinery of mosquitoes

Female blood-feeding mosquitoes, some species of which can transmit deadly diseases such as malaria and dengue to humans, largely find their human blood meals by detecting carbon dioxide emitted when people exhale.

2 Jun 2011

Google launches Dengue Trends tool to track outbreaks

"Google has launched Dengue Trends, a tool that aims to detect dengue fever outbreaks around the world using the same methodology behind Google Flu Trends," PC Magazine reports.

2 Jun 2011

Niiki Pharma to present NKP-1339 Phase I trial against metastatic cancer at ASCO 2011

Niiki Pharma announced today that it will present interim data from the ongoing Phase I clinical study for its lead product, NKP-1339, at the 2011 American Society for Clinical Oncology meeting in Chicago, IL.

2 Jun 2011

Scientists find increases in rain and temperature could signal deadly cholera outbreaks months before they strike

With recent deadly cholera outbreaks in Haiti and Cameroon providing the latest indication of a menacingly resurgent disease, scientists have discovered rain and temperature fluctuations in at-risk areas could predict epidemics months in advance, according to a new study published today in the June 2011 issue of the American Journal of Tropical Medicine and Hygiene.

1 Jun 2011

Novartis employees to do volunteer work for non-profit groups during 15th annual Community Partnership Day

Some 200 employees of Novartis Pharmaceuticals Canada Inc. will again this year be helping out with cleaning, painting and various other chores and activities at 15 Montreal-area organizations as part of their 15th annual Community Partnership Day, during which they leave their offices for the day to do volunteer work for non-profit groups. It is part of a global effort by Novartis employees that involves 20,000 employees in 55 countries.

30 May 2011

Medicago, USAMRIID enter research collaboration for Ebola vaccine candidate

Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has entered into a research collaboration agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) for the development of a plant-based VLP vaccine candidate for the prevention of Ebola. Ebola is a very serious hemorrhagic fever virus for which no licensed treatment or vaccine exists.

26 May 2011

Paxil and Pravachol in combination cause unexpected increase in blood glucose levels

A widely used combination of two common medications may cause unexpected increases in blood glucose levels, according to a study conducted at the Stanford University School of Medicine, Vanderbilt University and Harvard Medical School. Researchers were surprised at the finding because neither of the two drugs - one, an antidepressant marketed as Paxil, and the other, a cholesterol-lowering medication called Pravachol - has a similar effect alone.

26 May 2011

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present updated results for a Phase 1 study of VB-111 in patients with advanced metastatic cancer at the upcoming Annual Meeting of the American Society of Clinical Oncology, taking place June 3-7, 2011, at McCormick Place in Chicago.

24 May 2011

Inotuzumab ozogamicin achieves over 50% response rate against acute lymphoblastic leukemia

An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.

24 May 2011

First nucleic acid amplification test to diagnose early stages of Q fever infections receives FDA approval

The U.S. Food and Drug Administration today cleared the first nucleic acid amplification test to diagnose the early stages of Q fever infections in military personnel serving overseas.

21 May 2011

Most paediatric paracetamol prescriptions fails to comply with BNFc recommendations

Many of the prescriptions issued by GPs for paracetamol either give less than recommended doses to older children or exceed recommended doses in young children.

20 May 2011

Bitter cumin contains high levels of antioxidants and protects against DNA damage

Bitter cumin is used extensively in traditional medicine to treat a range of diseases from vitiligo to hyperglycemia. It is considered to be antiparasitic and antimicrobial and science has backed up claims of its use to reduce fever or as a painkiller. New research published in BioMedCentral's open access journal BMC Complementary and Alternative Medicine shows that this humble spice also contains high levels of antioxidants.

20 May 2011

Panel votes 20-0 for reformed labeling of kids’ pain & fever relieving medication

A federal advisory panel unanimously recommended that dosing for children's acetaminophen be based primarily on the child's weight rather than age. At present the dosing for children's products including acetaminophen- best known by the brand name Tylenol- is based on age, although many labels also contain information on dosing by weight as well. Acetaminophen is the most commonly used medicine meant to lower fever and relieve pain in children.

19 May 2011

JCO publishes Micromet's blinatumomab Phase 2 trial data in acute lymphoblastic leukemia

Micromet, Inc. today announced that data from a Phase 2 clinical trial of the Company's lead product candidate blinatumomab in patients with minimal residual disease positive acute lymphoblastic leukemia were published in the May 16th on-line edition of the Journal of Clinical Oncology.

18 May 2011

Q Fever News and Research

GAVI welcomes lower pentavalent vaccine price

Ross River Fever vaccine trials begin

MRSA found in cow’s milk

American College of Gastroenterology offers resources on foodborne illness, tips for food safety

New Kaiser Family Foundation tool shows which global health interventions are working

Flu cases rise by 50% in Queensland: Residents alerted

New study identifies odor molecules that disrupt CO2-sensing machinery of mosquitoes

Google launches Dengue Trends tool to track outbreaks

Niiki Pharma to present NKP-1339 Phase I trial against metastatic cancer at ASCO 2011

Scientists find increases in rain and temperature could signal deadly cholera outbreaks months before they strike

Novartis employees to do volunteer work for non-profit groups during 15th annual Community Partnership Day

Medicago, USAMRIID enter research collaboration for Ebola vaccine candidate

Paxil and Pravachol in combination cause unexpected increase in blood glucose levels

VBL to present updated VB-111 Phase 1 trial results in advanced metastatic cancer at ASCO 2011

Inotuzumab ozogamicin achieves over 50% response rate against acute lymphoblastic leukemia

First nucleic acid amplification test to diagnose early stages of Q fever infections receives FDA approval

Most paediatric paracetamol prescriptions fails to comply with BNFc recommendations

Bitter cumin contains high levels of antioxidants and protects against DNA damage

Panel votes 20-0 for reformed labeling of kids’ pain & fever relieving medication

JCO publishes Micromet's blinatumomab Phase 2 trial data in acute lymphoblastic leukemia

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News